Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah A Knight

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Plos One|April 13, 2011
Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccinesTroels R Petersen, Dianne Sika-Paotonu, Deborah A Knight, et al.
American Journal of Clinical Pathology|October 17, 2003
The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with sclerodermaRaghav Wusirika, Clodoveo Ferri, Mary Marin, et al.
Chemical Research in Toxicology|October 19, 2004
Macrophage-mediated endothelial inflammatory responses to airborne particulates: impact of particulate physicochemical propertiesRobert Kristovich, Deborah A Knight, John F Long, et al.
Vaccine|November 2, 2010
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunityRebecca C Girvan, Deborah A Knight, Chris J O'Loughlin, et al.
Immunology and Cell Biology|February 10, 2010
Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligandTroels R Petersen, Dianne Sika-Paotonu, Deborah A Knight, et al.
Oncogene|September 15, 2005
Y-box factor YB1 controls p53 apoptotic functionCraig Homer, Deborah A Knight, Lynne Hananeia, et al.
International Journal of Nanomedicine|March 12, 2015
Uptake of bright fluorophore core-silica shell nanoparticles by biological systemsAndrew Zane, Christie McCracken, Deborah A Knight, et al.
American Journal of Clinical Pathology|January 11, 2007
The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular diseaseCynthia M Magro, Patrick Ross, Clay B Marsh, et al.
Human Immunology|May 25, 2006
Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodiesCynthia M Magro, W James Waldman, Deborah A Knight, et al.
Carbohydrate Research|April 6, 2011
An improved synthesis of dansylated α-galactosylceramide and its use as a fluorescent probe for the monitoring of glycolipid uptake by cellsJanice M H Cheng, Stephanie H Chee, Deborah A Knight, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Plos One|April 13, 2011
Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccinesTroels R Petersen, Dianne Sika-Paotonu, Deborah A Knight, et al.
American Journal of Clinical Pathology|October 17, 2003
The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with sclerodermaRaghav Wusirika, Clodoveo Ferri, Mary Marin, et al.
Chemical Research in Toxicology|October 19, 2004
Macrophage-mediated endothelial inflammatory responses to airborne particulates: impact of particulate physicochemical propertiesRobert Kristovich, Deborah A Knight, John F Long, et al.
Vaccine|November 2, 2010
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunityRebecca C Girvan, Deborah A Knight, Chris J O'Loughlin, et al.
Immunology and Cell Biology|February 10, 2010
Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligandTroels R Petersen, Dianne Sika-Paotonu, Deborah A Knight, et al.
Oncogene|September 15, 2005
Y-box factor YB1 controls p53 apoptotic functionCraig Homer, Deborah A Knight, Lynne Hananeia, et al.
International Journal of Nanomedicine|March 12, 2015
Uptake of bright fluorophore core-silica shell nanoparticles by biological systemsAndrew Zane, Christie McCracken, Deborah A Knight, et al.
American Journal of Clinical Pathology|January 11, 2007
The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular diseaseCynthia M Magro, Patrick Ross, Clay B Marsh, et al.
Human Immunology|May 25, 2006
Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodiesCynthia M Magro, W James Waldman, Deborah A Knight, et al.
Carbohydrate Research|April 6, 2011
An improved synthesis of dansylated α-galactosylceramide and its use as a fluorescent probe for the monitoring of glycolipid uptake by cellsJanice M H Cheng, Stephanie H Chee, Deborah A Knight, et al.
Pageof 4